Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Actos
Generic name / active ingredient
pioglitazone
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral
Record reviewed
2026-08-23

Copy from the pack in hand

Source-linked reading points

  • Check ACTOS, pioglitazone, oral tablet, labelled strength per tablet and target market together. A shared glucose-lowering purpose or nearby mg number does not prove it can be self-combined, alternated or substituted with metformin, insulin, sulfonylureas or another product.
  • The label flags fluid-retention and heart-failure-related risks for attention. Rapid weight change, swelling, breathing symptoms or another new concern cannot be diagnosed by a webpage; bring the actual package and complete medicine list to local medical and prescribing teams promptly.
  • With insulin or another glucose-lowering medicine, relevant label risks cannot be excluded by brand name alone. Do not self-increase, reduce, make up or stop because of one glucose value, a missed meal, exercise change or concern about symptoms.
  • Any liver, heart, eye, bone or pregnancy-related issue, and any start, stop or conversion plan, need professional judgement using the exact product and current label.

Reviewed presentation examples — compare every field

  • Pioglitazone 15 mg per tablet; 30-tablet bottleNDC 64764-151-04
  • Pioglitazone 30 mg per tablet; 30-tablet bottleNDC 64764-301-14
  • Pioglitazone 45 mg per tablet; 30-tablet bottleNDC 64764-451-24

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-23
Source record
1 clickable primary-source entry point is listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image